Agenda

Return

C. 94

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	December 7, 2021

Contra

Costa

County

Subject:

Purchase Order with ASD Healthcare

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 12/07/2021

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Jaspreet Benepal, 925-370-5501
cc:	M Wilhelm I Segovia

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: December 7, 2021
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Department, a Purchase Order with ASD Healthcare, in an amount not to exceed $795,000 for the purchase of Remdesivir medication for the Contra Costa Regional Medical Center (CCRMC) Pharmacy for the period January 1, 2022 through December 31, 2022.

FISCAL IMPACT:

Approval of this purchase order will result in $795,000 of additional annual expenditures and will be funded 100% by the American Rescue Plan Act (ARPA) allocations.

BACKGROUND:

CCRMC Pharmacy Department has been purchasing Remdesivir for the treatment of COVID-19 patients at CCRMC from ASD Healthcare. ASD Healthcare is the only Federal Government authorized distributer. Remdesivir prevents the virus from producing a particular enzyme that is necessary for the virus to replicate itself. Once this happens, the virus is no longer able to spread within the body. Research shows that when patients with moderate cases of COVID-19 receive Remdesivir, their symptoms improve more quickly. The drug has also been shown to shorten the duration of patient hospital stays. Among severely ill COVID-19 patients, Remdesivir has been associated with fewer deaths. Only hospitalized COVID-19 patients may be treated with Remdesivir, whether they have mild, moderate, or severe disease. ASD Healthcare, by the FDA ruling, is the sole source for providing Remdesivir. Wholesalers do not carry this medication at this time.

CONSEQUENCE OF NEGATIVE ACTION:

If this purchase order is not approved, the County will not be able to purchase Remdesivir that is needed for treating our COVID-19 patients, which could cause a negative impact in the health of our patients at CCRMC.